The rapid advancement of trial technologies such as remote monitoring, wearable devices, state-of-the-art data analysis tools and more have expanded the realm of possibilities in research. The arrival of the COVID-19 pandemic has served to accelerate adoption of such technologies, empowering sites and sponsors to continue their work despite the obstacles created by travel restrictions, facility closures and other circumstances.
Professionals interested in these technologies—and in the future of the clinical trial industry—are invited to join us on December 9 for Digital Advances in Clinical Trials: Clinical Development. This virtual event will feature insight and advice from a number of experts in the field, each offering a unique perspective on how digital innovation are impacting research and moving trials forward.
During the first part of this one-hour editorial webinar, presenters will discuss innovative technologies, wearable devices, patient engagement and enrollment, and more. Experts scheduled to enlighten attendees include representatives from Bristol Myers Squibb, Scripps Research and the University of South Florida.
The second part is where attendees come in. During the question-and-answer session, participants are invited to ask any questions that come to mind, then the expert presenters will offer their thoughts.
A big thank-you is due to our sponsors, whose support makes informative events like this possible:
- Ajinomoto Biopharma Services
- Elligo Health Research
- Oracle Health Sciences
Registration is now open for this dynamic, free online event. Sign up today for Digital Advances in Clinical Trials: Clinical Development and join your industry colleagues in a lively discussion about the future direction of clinical research.